Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-2 of 2
Keywords: Bacillus Calmette-Guérin immunotherapy
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Reduction of Bladder Volume after BCG Immunotherapy
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2021) 105 (1-2): 155–158.
Published Online: 03 September 2020
... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Bladder cancer Bacillus Calmette-Guérin immunotherapy Adverse effects Bladder volume Bladder cancer is a common malignant tumor of urinary system, which can be divided...
Journal Articles
A Trial of Bacillus Calmette-Guérin versus Adriamycin in Superficial Bladder Cancer: A South-West Oncology Group Study
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (1986) 41 (4): 254–259.
Published Online: 29 January 2010
... to adriamycin chemotherapy in the prevention of recurrent superficial transitional cell carcinoma and the treatment of in situ carcinoma of the urinary bladder. Bacillus Calmette-Guérin immunotherapy Adriamycin, intravesical Cancer, superficial bladder © 1986 S. Karger AG, Basel 1986 Copyright...